| MolName | 2-[2-bromo-4-[(Z)-[2,4-dioxo-3-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-N-phenylacetamide |
| MolecularFormula | C30H27N4O5BrS |
| Smiles | O=C(COc(ccc(/C=C(/C(N1CC(N(CC2)CCN2c2ccccc2)=O)=O)\SC1=O)c1)c1Br)Nc1ccccc1 |
| InChI | InChI=1S/C30H27BrN4O5S/c31-24-17-21(11-12-25(24)40-20-27(36)32-22-7-3-1-4-8-22)18-26-29(38)35(30(39)41-26)19-28(37)34-15-13-33(14-16-34)23-9-5-2-6-10-23/h1-12,17-18H,13-16,19-20H2,(H,32,36) |
| InChIK | OVFGMSPMBGDQRD-UHFFFAOYSA-N |
| TotalMolweight | 635.537 |
| Molweight | 635.537 |
| MonoisotopicMass | 634.088552 |
| CLogP | 4.1137 |
| CLogS | -5.732 |
| H Acceptors | 9 |
| H Donors | 1 |
| TotalSurfaceArea | 432.53 |
| Relative PSA | 0.23527 |
| PolarSurfaceArea | 124.56 |
| Druglikeness | 6.4422 |
| Mutagenic | none |
| Tumorigenic | none |
| Reproductive Effective | none |
| Irritant | none |
| Nasty Functions | limit! methylene-thiazolidine-2,4-dione |
| Shape Index | 0.63415 |
| Fragments | 1 |
| Non HAtoms | 41 |
| NonCHAtoms | 11 |
| Electronegative Atoms | 11 |
| Rotatable Bond | 8 |
| Rings Closures | 5 |
| Small Rings | 5 |
| Aromatic Rings | 3 |
| Aromatic Atoms | 18 |
| Sp3Atoms | 8 |
| Symmetricatoms | 6 |
| Amides | 3 |
| Amines | 1 |
| Aromatic Amines | 1 |
| StereoCon |
Click to Load Molecule:
1 - 2-[2-bromo-4-[(Z)-[2,4-dioxo-3-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-N-phenylacetamide | 2 - 2-[2-bromo-4-[(Z)-[2,4-dioxo-3-[2-oxo-2-(4-phenylpiperazin-1-yl)ethyl]-1,3-thiazolidin-5-ylidene]methyl]phenoxy]-N-phenylacetamide